| Enddatum des Zeitraums | 2026-06-30 | 2026-03-31 | 2025-12-31 | 2025-09-30 | 2025-06-30 |
|---|---|---|---|---|---|
| Periodenlänge | 3 Monate | 3 Monate | 3 Monate | 3 Monate | 3 Monate |
| Revenues | 18.33%364.71 | 308.21 | 296.09 | 277.11 | 257.29 |
10.88%350.07 | 315.73 | 277.17 | 253.44 | 252.75 | |
| Research and Development | 17.16%93.86 | 80.11 | 66.91 | 64.03 | 68.83 |
| Operating Income/Loss | 294.72%14.64 | -7.52 | 18.92 | 23.67 | 4.54 |
| Net Interest Income/Expense | 46.43%16.69 | 31.15 | 30.87 | 18.57 | 16.51 |
| Income Tax Expense/Benefit | 630.95%0.61 | 0.08 | 0.53 | 0.12 | 0.05 |
348.86%16.54 | -6.65 | 18.64 | 31.81 | 5.61 | |
| Attributable To Parent | 348.86%16.54 | -6.65 | 18.64 | 31.81 | 5.61 |
| Available To Common Stockholders, Basic | 348.86%16.54 | -6.65 | 18.64 | 31.81 | 5.61 |
| Basic Average Shares | 0.34%96.57 | 96.90 | 0.53 | 96.68 | 95.53 |
| Diluted Average Shares | 13.23%109.72 | 96.90 | 1.57 | 109.72 | 102.85 |
| Basic Earnings Per Share | 342.86%0.17 | -0.07 | 0.19 | 0.33 | 0.06 |
| Diluted Earnings Per Share | 328.57%0.16 | -0.07 | 0.17 | 0.23 | 0.05 |